Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...

A disrupted sleep pattern directly impacts your health. According to an American study published in the journal Neurology, ...

Alzheimer's disease progresses gradually, with subtle behavioral changes often appearing long before a formal diagnosis.

But there's a catch: New research suggests that those blood tests may be unreliable, especially in Black patients. Doctors ...

But a new study looking at the anti-amyloid drug gantenerumab could change all that. Published in the Lancet Neurology ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips.

Panelists discuss how significant knowledge gaps among nonspecialist providers—particularly regarding differential diagnosis, interpretation of cognitive assessments, and awareness of treatment ...

Alzheimer’s is a complex disease that presents many challenging symptoms for caregivers to manage. Ukiah Alzheimer’s ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

The Alzheimer’s Disease Research Center (ADRC) at the University of Pittsburgh is one of the country’s hubs for researchers ...